Skip to content
Screener

Ashland ASH Life Sciences — Cost Of Revenue

Other segment segments

Specialty Additives
$110M-10.6%
Personal Care And Household
$90M+3.4%
Intermediates And Solvents
$32M+14.3%

Similar metrics at other companies

RDI
RDILive Theater Cost — Cost Of Revenue
$272K+14.8%
Verb Technology Company, Inc. logo
TONXMarket Live — Cost Of Revenue
$964K+127%
RFL
RFLCost Of Product Revenue — Cost Of Revenue
$8K-11.1%
Forrester Research logo
FORRDirect Costs Of Events — Cost Of Revenue
$7.09M-21.0%
BTCS logo
BTCSBlockchain Infrastructure Revenues — Cost Of Revenue
$1.12M-28.3%
BTCS logo
BTCSDe Fi Revenues — Cost Of Revenue
$9.08K—

Other financials

Income statement

See full
Revenue$497.0M+7.3%
Gross profit$170.0M+28.8%
Operating income$43.0M+106%
Net income$16.0M+102%
EPS (diluted)$0.35+102%

Balance sheet

See full
Cash & equivalents$440.0M+113%
Total debt$1.5B-0.6%
Total equity$1.9B-1.0%
Total assets$4.6B-0.9%

Cash flow

See full
Operating cash flow$120.0M+4.3%
CapEx$20.0M0.0%
Free cash flow$100.0M+5.3%

Valuation

See full
Market cap$3.32B+40.6%
Enterprise value$4.35B+19.7%
P/E165.9×—
P/S1.8×+0.5×

Profitability

See full
Gross margin31.5%+1.4pp
Operating margin4.1%—
Net margin1.1%+0.5pp
FCF margin13.6%+9.7pp

Returns & leverage

See full
Return on equity1.1%+0.5pp
Debt / equity0.8×0.0×
Current ratio3×+0.4×

Where this comes from

Reported directly by Ashland in its filing.

Tagged under the XBRL concept us-gaap:CostOfRevenue.

The source filing: Ashland’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 5:17 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-324226
(In millions - unaudited)Three months ended / June 30 / 2026Three months ended / June 30 / 2025Nine months ended / June 30 / 2026Nine months ended / June 30 / 2025
Intersegment sales(a)(11)(10)(29)(31)
$497$463$1,365$1,347
Cost of sales
Life Sciences$106$103$308$311
Personal Care9087257256
Specialty Additives110123317328
Intermediates32289093
Intersegment sales(11)(10)(29)(31)

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Ashland's life sciences — cost of revenue?
Ashland (ASH) reported life sciences — cost of revenue of $106M in Q2 2026.
How has Ashland's life sciences — cost of revenue changed year-over-year?
Ashland's life sciences — cost of revenue increased by 2.9% year-over-year, from $103M to $106M.
What is the long-term trend for Ashland's life sciences — cost of revenue?
Over 2 years (2023 to 2025), Ashland's life sciences — cost of revenue has grown at a -14.2% compound annual growth rate (CAGR), from $568M to $418M.
What does life sciences — cost of revenue mean?
This represents the direct costs attributable to the production of goods or the delivery of services sold by the segment, including raw materials, labor, and manufacturing overhead. It is a key measure of operational efficiency and direct margin management. Monitoring this metric helps assess the impact of input price inflation and production productivity on profitability.

Ask your AI about Ashland's life sciences — cost of revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude